Labelled MDV 3100. MDV 3100 is an androgen-receptor antagonist that blocks androgens from binding to the androgen receptor and prevents nuclear translocation and co-activator recruitment of the ligand-receptor complex. MDV 3100 has also been shown to induce tumor cell apoptosis, and has no agonist activity. MDV 3100 is a candidate for the treatment of castration-resistant prostate cancer.
|Catalog Number||RCL-TR- 199802|
|Chemical Name||MDV 3100-d3|
|Boiling Pt||No Data Available|
|Stability||No Data Available|
|Solubility||Chloroform (Slightly), Ethyl Acetate (Slightly)|
|HS Commidity Code||2845.90.0000|